Diarylquinolines target subunit c of mycobacterial ATP synthase
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The diarylquinoline R207910 (TMC207) is a promising candidate in clinical development for the treatment of tuberculosis. Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compound's precise target is not known. Here we establish by genetic, biochemical and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910. Thus targeting energy metabolism is a new, promising approach for antibacterial drug discovery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most promising compounds clinically, the diarylquinolines, have been shown to target the F1Fo-ATP synthase and inhibit ATP synthesis (109, 111, 112).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [111]
Citations
Cites
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Self-citationMolecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
de Jonge, M. R., Koymans, L. H. M., Guillemont, J. E. G., Koul, A., & Andries, K. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21376 · Cited by 124
Self-citationThe F 1 F o -ATP Synthase of Mycobacterium smegmatis Is Essential for Growth
Tran, S. L., & Cook, G. M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.14.5023-5028.2005 · Cited by 116
Ji, B., Lefrançois, S., Robert, J., Chauffour, A., Truffot-Pernot, C., & Jarlier, V. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00052-06 · Cited by 107
Wang, R., Prince, J. T., & Marcotte, E. M. (2005) · Genome Research · doi:10.1101/gr.3994105 · Cited by 86
Junge, W., & Nelson, N. (2005) · Science · doi:10.1126/science.1112617 · Cited by 60
Cited by
Items 301–400 of 571
Bald, D., & Koul, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.09.007 · Cited by 30
Self-citationTelacebec: an investigational antibacterial for the treatment of tuberculosis (TB)
Lee, B. S., & Pethe, K. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2030309 · Cited by 20
Current possibilities and unresolved issues of drug target validation inMycobacterium tuberculosis
Sharma, U. K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.626763 · Cited by 20
Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials
Ahsan, M. J., Ansari, M. Y., Yasmin, S., Jadav, S. S., Kumar, P., Garg, S., Ajay, A., & Khalilullah, H. (2014) · Infectious Disorders - Drug Targets · doi:10.2174/1871526514666140923153329 · Cited by 20
Filling the Pipeline - New Drugs for an Old Disease
Stehr, M., Elamin, A. A., & Singh, M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026613666131113152908 · Cited by 28
Defelipe, L. A., Porto, D. F. D., Ramos, P. I. P., Nicolás, M., Sosa, E. J., Radusky, L., Lanzarotti, E., Turjanski, A. G., & Marti, M. A. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.11.009 · Cited by 23
Choi, P. J., Conole, D., Sutherland, H. S., Blaser, A., Tong, A. S. T., Cooper, C. B., Upton, A. M., Palmer, B. D., & Denny, W. A. (2020) · Molecules · doi:10.3390/molecules25061423 · Cited by 19
The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053
Albesa-Jové, D., Comino, N., Tersa, M., Mohorko, E., Urresti, S., Dainese, E., Chiarelli, L. R., Pasca, M. R., Manganelli, R., Makarov, V., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677039 · Cited by 19
Structure, Mechanism and Regulation of ATP Synthases
Walker, J. E. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781788010405-00338 · Cited by 19
Gray, W. A., Waldorf, B., Rao, M. G., Stiles, B. L., Griffiss, J. M., Salata, R. A., & Blumer, J. L. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.07.023 · Cited by 20
Gouws, A. C., Kruger, H. G., Gheysens, O. S., Zeevaart, J. R., Govender, T., Naicker, T., & Ebenhan, T. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204955 · Cited by 20
Targeting polyketide synthase 13 for the treatment of tuberculosis
Xia, F., Zhang, H., Yang, H., Zheng, M., Min, W., Sun, C., Yuan, K., & Yang, P. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115702 · Cited by 21
A simple assay for inhibitors of mycobacterial oxidative phosphorylation
Harden, S. A., Courbon, G. M., Liang, Y., Kim, A. S., & Rubinstein, J. L. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105483 · Cited by 14
Genetics and roadblocks of drug resistant tuberculosis
Perdigão, J., & Portugal, I. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.09.023 · Cited by 19
Karkara, B. B., Mishra, S. S., Singh, B. N., & Panda, G. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103775 · Cited by 18
Tuberculosis: current scenario, drug targets, and future prospects
Bose, P., Harit, A. K., Das, R., Sau, S., Iyer, A. K., & Kashaw, S. K. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02691-5 · Cited by 19
Mutational Analysis of Mycobacterial F-ATP Synthase Subunit δ Leads to a Potent δ Enzyme Inhibitor
Harikishore, A., Saw, W. G., Ragunathan, P., Litty, D., Dick, T., Müller, V., & Grüber, G. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00766 · Cited by 18
Fungicides Acting on Oxidative Phosphorylation
Earley, F. G. P., Sauter, H., Rheinheimer, J., Rieck, H., Coqueron, P., Whittingham, W. G., & Walter, H. (2011) · Wiley eBooks · doi:10.1002/9783527644179.ch15 · Cited by 19
Whole-Genome Sequencing for Comparative Genomics and De Novo Genome Assembly
Benjak, A., Sala, C., & Hartkoorn, R. C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2450-9_1 · Cited by 18
Response of Mycobacterium smegmatis to the Cytochrome bcc Inhibitor Q203
Chauhan, P., van der Meulen, S. A., Caetano, J. M. S., Goojani, H. G., Botman, D., van Spanning, R. J. M., Lill, H., & Bald, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810331 · Cited by 17
Self-citationZhou, Y., Shao, M., Wang, W., Cheung, C., Wu, Y., Yu, H., Hu, X., Cook, G. M., Gong, H., & Lu, X. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114896 · Cited by 17
Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis
Johnson, T. M., Rivera, C. G., Lee, G., & Zeuli, J. D. (2024) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2024.100470 · Cited by 17
Osterman, A. L., Rodionova, I. A., Li, X., Sergienko, E. A., Ma, C.-T., Catanzaro, A., Pettigrove, M. E., Reed, R. W., Gupta, R., Rohde, K. H., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00124 · Cited by 17
Two Decades of TB Drug Discovery Efforts—What Have We Learned?
Bandodkar, B., Shandil, R. K., Bhat, J. J., & Balganesh, T. S. (2020) · Applied Sciences · doi:10.3390/app10165704 · Cited by 19
Hughes, J. A., Solans, B. P., Draper, H. R., Schaaf, H. S., Winckler, J. L., van der Laan, L., Radtke, K. K., Fourie, B., Wiesner, L., Hesseling, A. C., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac252 · Cited by 17
On the ATP binding site of the ε subunit from bacterial F-type ATP synthases
Krah, A., & Takada, S. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.01.007 · Cited by 19
Singh, P., Kumar, S., Maurya, V. K., Mehta, B. K., Ahmad, H., Dwivedi, A. K., Chaturvedi, V., Thakur, T. S., & Sinha, S. K. (2017) · ACS Omega · doi:10.1021/acsomega.7b01281 · Cited by 17
Management of drug resistantTB in patients with HIV co-infection
Pontali, E., Sotgiu, G., Centis, R., D’Ambrosio, L., Spanevello, A., & Migliori, G. B. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1100169 · Cited by 16
New antituberculosis drugs targeting the respiratory chain
Li, Q., & Lu, X. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.04.007 · Cited by 17
Lobo, M. J., Ray, R., & Shenoy, G. G. (2020) · New Journal of Chemistry · doi:10.1039/d0nj02062a · Cited by 16
An energetic profile of Corynebacterium glutamicum underpinned by measured biomass yield on ATP
Zelle, E., Pfelzer, N., Oldiges, M., Koch-Koerfges, A., Bott, M. H., Nöh, K., & Wiechert, W. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.03.006 · Cited by 18
Park, H.-E., Lee, W., Shin, M., & Shin, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703060 · Cited by 16
Bown, L., Srivastava, S. K., Piercey, B. M., McIsaac, C. K., & Tahlan, K. (2017) · The Journal of Membrane Biology · doi:10.1007/s00232-017-9997-3 · Cited by 16
Cook, G. M., Hards, K., Dunn, E. A., Heikal, A., Nakatani, Y., Greening, C., Crick, D. C., Fontes, F. L., Pethe, K., Hasenoehrl, E., et al. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch14 · Cited by 18
Advances in Drug Discovery and Development for Pediatric Tuberculosis
Hoagland, D. T., Zhao, Y., & Lee, R. E., Jr. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150722101723 · Cited by 16
Bedaquiline for the treatment of drug-resistant tuberculosis
Bélard, S., Heuvelings, C. C., Janssen, S., & Grobusch, M. P. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1021785 · Cited by 15
Salina, E. G., Riabova, O., Vocat, A., Nikonenko, B. V., Cole, S. T., & Makarov, V. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.04.012 · Cited by 18
Chakraborti, S., Chakraborty, M., Bose, A., Srinivasan, N., & Visweswariah, S. S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.599221 · Cited by 15
Designing and testing single tablet for tuberculosis treatment through electrospinning
Hassounah, I., Shehata, N., Kimsawatde, G. C., Hudson, A. G., Sriranganathan, N., Joseph, E. G., & Mahajan, R. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-41533-0.00011-8 · Cited by 17
Yao, G., Zhu, M., Nie, Q., Chen, N., Tu, S., Zhou, Y., Xiao, F., Liu, Y., Li, X., & Chen, H. (2023) · Journal of International Medical Research · doi:10.1177/03000605221148416 · Cited by 14
Food for thought: Opportunities to target carbon metabolism in antibacterial drug discovery
Tong, M., & Brown, E. D. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14991 · Cited by 15
Asymmetric Synthesis and Absolute Configuration Assignment of a New Type of Bedaquiline Analogue
Qiao, C.-J., Wang, X., Xie, F., Zhong, W., & Li, S. (2015) · Molecules · doi:10.3390/molecules201219846 · Cited by 14
News on therapeutic management of MDR-tuberculosis: a literature review
Barthod, L., Lopez, J. G., Curti, C., Bornet, C., Roche, M., Montana, M., & Vanelle, P. (2017) · Journal of Chemotherapy · doi:10.1080/1120009x.2017.1338845 · Cited by 14
Syed, T., Asiri, Y. I., & Alshehri, J. A. (2019) · Letters in Organic Chemistry · doi:10.2174/15701786otg54otuctcvy · Cited by 14
Fekadu, G., Tolossa, T., Bekele, F., Chen, X., He, Y., Yu, J., Yi, X., Liu, M., Fetensa, G., Dugassa, D., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-018220 · Cited by 14
Application of antimicrobial drugs in Mycobacterium tuberculosis and research progress
Wang, Y., Cao, D., & Liu, G. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107794 · Cited by 13
Perveen, S., Pal, S., & Sharma, R. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00829d · Cited by 15
Structure of Mycobacterial NDH-2 Bound to a 2-Mercapto-Quinazolinone Inhibitor
Liang, Y., Bueler, S. A., Cook, G. M., & Rubinstein, J. L. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00049 · Cited by 13
Salifu, E. Y., Agoni, C., Olotu, F. A., Dokurugu, Y. M., & Soliman, M. E. S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28891 · Cited by 13
Mitochondrial Targeting for Drug Development
Pourahmad, J., Salimi, A., & Seydi, E. (2015) · InTech eBooks · doi:10.5772/59719 · Cited by 13
Krah, A., Marzinek, J. K., & Bond, P. J. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.02.010 · Cited by 13
Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB
Mikati, M. O., Miller, J. J., Osbourn, D. M., Barekatain, Y., Ghebremichael, N., Shah, I. T., Burnham, C. D., Heidel, K. M., Yan, V. C., Müller, F. L., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00582 · Cited by 13
Jantová, S., Repický, A., Letašiová, S., & Čipák, L. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1485 · Cited by 13
Drug resistant tuberculosis: Current scenario and impending challenges
Dewhare, S. S. (2021) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2021.04.008 · Cited by 13
Srinivas, V., Ruiz, R. A., Pan, M., Immanuel, S. R. C., Peterson, E. J. R., & Baliga, N. S. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100123 · Cited by 14
McNeil, M. B., Cheung, C., Waller, N. J. E., Adolph, C., Chapman, C. L., Seeto, N. E. J., Jowsey, W. J., Li, Z., Hameed, H. M. A., Zhang, T., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.980844 · Cited by 15
Можокина, Г. Н., Samoylova, А. G., Vasilyeva, I. A., & Russkikh, A. (2022) · Tuberculosis and lung diseases · doi:10.21292/2075-1230-2022-100-8-54-64 · Cited by 12
Kumar, A., Karkara, B. B., & Panda, G. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13934 · Cited by 14
Kim, S., Louie, A., Drusano, G. L., Almoslem, M., Kim, S., Myrick, J., Nole, J., Duncanson, B., Peloquin, C. A., Scanga, C. A., et al. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106509 · Cited by 12
Tomioka, H. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.1.21 · Cited by 13
Proteomic characterization of Mycobacterium tuberculosis subjected to carbon starvation
Devlin, K. L., Leach, D. T., Stratton, K. G., Lamichhane, G., Lin, V., & Beatty, K. E. (2025) · mSystems · doi:10.1128/msystems.01530-24 · Cited by 14
Vilchèze, C., Saranathan, R., Kalluru, R. S., Banaei, N., & Jacobs, W. R. (2025) · mBio · doi:10.1128/mbio.01484-25 · Cited by 11
Bedaquiline in Drug-Resistant Tuberculosis: A Mini-Review
Singh, B. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220421130707 · Cited by 11
Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis
Xiong, X., Xu, Z., Yang, Z., Liu, Y., Wang, D., Dong, M., Parker, E. J., & Zhu, W. (2013) · Current Drug Targets · doi:10.2174/1389450111314060009 · Cited by 12
Interaction of the anti-tuberculous drug bedaquiline with artificial membranes and rat erythrocytes
Belosludtsev, K. N., Penkov, N. V., Tenkov, K. S., Talanov, E. Y., Belosludtseva, N. V., Agafonov, A. V., Stepanova, A. E., Starinets, V. S., Ващенко, О. В., Gudkov, S. V., et al. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.017 · Cited by 11
Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis
Thompson, A. M., & Denny, W. A. (2019) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2019.05.001 · Cited by 14
Brown, A. K., Aljohani, A. K. B., Alsalem, F. M. A., Broadhead, J. L., Gill, J. H., Lu, Y., & Sellars, J. D. (2020) · Molecules · doi:10.3390/molecules25102387 · Cited by 12
ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines
Saxena, A. K., & Alam, M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200903163515 · Cited by 11
Milgrom, Y. M., & Duncan, T. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93098-8 · Cited by 11
Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review
Wani, M. A., & Dhaked, D. K. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10335-y · Cited by 11
Harbut, M. B., Yang, B., Liu, R., Yano, T., Vilchèze, C., Cheng, B., Lockner, J. W., Guo, H., Yu, C., Franzblau, S. G., et al. (2018) · Angewandte Chemie · doi:10.1002/ange.201800260 · Cited by 11
Synthesis, characterization and biological activity of fluorescently labeled bedaquiline analogues
Rombouts, J. A., Veenboer, R. M. P., Villellas, C., Lü, P., Ehlers, A. W., Andries, K., Koul, A., Lill, H., Ruijter, E., Orrù, R. V. A., et al. (2016) · RSC Advances · doi:10.1039/c6ra22693k · Cited by 12
Self-citationRachakonda, V., Kotapalli, S. S., Ummanni, R., & Alla, M. (2017) · ChemistrySelect · doi:10.1002/slct.201701241 · Cited by 11
Barbaro, L., Nagalingam, G., Triccas, J. A., Tan, L., West, N. P., Baell, J. B., & Priebbenow, D. L. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00063b · Cited by 11
Perveen, S., Negi, A., Saini, S., Gangwar, A., & Sharma, R. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00463 · Cited by 10
Efficacy of epetraborole against Mycobacteroides abscessus in a mouse model of lung infection
Rimal, B., Lippincott, C. K., Panthi, C. M., Xie, Y., Keepers, T. R., Alley, M. R. K., & Lamichhane, G. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00648-24 · Cited by 11
Maeda, M. (2008) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-008-9135-0 · Cited by 11
Multidrug- and extensively drug-resistant TB in persons living with HIV
Matteelli, A., Richardson, M. D. A., Sotgiu, G., Centis, R., & Migliori, G. B. (2009) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.15 · Cited by 10
Advances in host‐based screening for compounds with intracellular anti‐mycobacterial activity
Subhash, N., & Sundaramurthy, V. (2021) · Cellular Microbiology · doi:10.1111/cmi.13337 · Cited by 10
Chasák, J., Oorts, L., Dak, M., Šlachtová, V., Bazgier, V., Berka, K., Vooght, L. D., Smiejkowska, N., Calster, K. V., Moll, L. V., et al. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117504 · Cited by 9
Hassounah, I., Shehata, N., Kimsawatde, G. C., Hudson, A. G., Sriranganathan, N., Joseph, E. G., & Mahajan, R. L. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35070 · Cited by 9
Singh, R., Ramachandran, V., Shandil, R. K., Sharma, S., Khandelwal, S., Karmarkar, M., Kumar, N., Solapure, S. M., Saralaya, R., Nanduri, R., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05148-14 · Cited by 9
Zhang, M., Yu, W., Zhou, S., Zhang, B., Lo, E. C. M., Xu, X., & Zhang, D. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.647611 · Cited by 10
On the Mg2+ binding site of the ε subunit from bacterial F-type ATP synthases
Krah, A., & Takada, S. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.018 · Cited by 10
Reddyrajula, R., Etikyala, U., Mahapathra, H. C., Udaybhan, R. A., Manga, V., & Dalimba, U. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.140696 · Cited by 8
Vadankula, G. R., Nilkanth, V. V., Rizvi, A., Yandrapally, S., Agarwal, A., Chirra, H., Biswas, R., Arifuddin, M., Nema, V., Alvala, M., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00277 · Cited by 8
Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections
Strhársky, T., Pindjaková, D., Kos, J., Vráblová, L., Šmak, P., Michnová, H., Goněc, T., Hošek, J., Oravec, M., Jendrzejewska, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315090 · Cited by 8
Navigating tuberculosis drug discovery with target-based screening
Miller, C. H., & O’Toole, R. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.586999 · Cited by 10
Bhakta, S. (2013) · Molecular Biology · doi:10.4172/2168-9547.1000e108 · Cited by 8
Ramírez, L. M. N., Mehaffy, C., & Dobos, K. M. (2018) · InTech eBooks · doi:10.5772/intechopen.69594 · Cited by 8
(2008) · Tuberculosis · doi:10.1016/s1472-9792(08)70029-5 · Cited by 8
Berg, K. G., Hegde, P. V., Pujari, V., Brinkmann, M., Wilkins, D. Z., Parish, T., Crick, D. C., & Aldrich, C. C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115125 · Cited by 7
Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
Jang, J., Jung, Y., Choi, J., Jung, H., & Ryoo, S. (2017) · The Journal of Microbiology · doi:10.1007/s12275-017-6630-1 · Cited by 7
Shahbaaz, M., Cloete, R. E. A., Grobbelaar, M., Sampson, S. L., & Christoffels, A. G. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.05.108 · Cited by 7
Janeoo, S., Kaur, H., Kaul, G., Akhir, A., Chopra, S., Banerjee, S., Reenu, R., Kumar, V., & Kumar, R. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130924 · Cited by 9
Kumar, S., Saini, A., Kumar, A., Raj, R., & Kumar, V. (2022) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4486 · Cited by 7
Gomez, J. E., Clatworthy, A. E., & Hung, D. T. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.538663 · Cited by 8
Evaluating bedaquiline as a treatment option for multidrug-resistant tuberculosis
Martín-García, M., & Esteban, J. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1867538 · Cited by 8
Aldrich, C. C., Boshoff, H. I., & Remmel, R. P. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc231 · Cited by 7
Afifi, M., Amin, W., Bassiouni, D. A. R. H., Ashmawy, R., El‐Maradny, Y. A., Khalifa, N., & Ghazy, R. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-65063-8 · Cited by 6
Metadata
- Authors
- Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., Bald, D., & Andries, K.
- Affiliations
- Johnson & Johnson (United States) (US)
- Vrije Universiteit Amsterdam (NL)
- Johnson & Johnson (France) (FR)
- Corresponding author
- Koul, Anil
- Venue
- Nature Chemical Biology
- Published
- 2007-05-13
- Volume
- 3
- Issue
- 6
- Pages
- 323-324
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2093364655
- Cited by
- 547
- References
- 11
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 27 · 2023: 27 · 2022: 40 · 2021: 50 · 2020: 31 · 2019: 40 · 2018: 36 · 2017: 40 · 2016: 23 · 2015: 33 · 2014: 26 · 2013: 31 · 2012: 22
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- diarylquinolines, bedaquiline, subunit c, atpE, tuberculosis, drug target identification, drug resistance, energy metabolism, antibiotic discovery
- MeSH terms
- Antitubercular Agents, Bacterial Proteins, Binding Sites, Kinetics, Quinolines, Electrophoresis, Gel, Two-Dimensional, Mycobacterium smegmatis, Protein Subunits, ATP Synthetase Complexes, Bacterial Proton-Translocating ATPases, Diarylquinolines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.